What does an omega-3 deficiency do to your brain and mental resilience?
An omega-3 deficiency demonstrably harms the brain, particularly during early development and in depression. If you have symptoms of low mood and are already taking antidepressants, omega-3 as an add-on is the best-supported option; for Alzheimer's prevention, supplementation offers little benefit.
DHA is the most abundant fatty acid in the brain membrane and is essential for its construction. A deficiency during pregnancy or early in life impairs the cognitive development of the child. This relationship is considered probably causal, not merely a statistical pattern.
In adults, a low omega-3 blood level is associated with a smaller brain volume, faster decline in cognitive function, and a higher risk of stroke and premature death. These are associations from population studies; cause and effect have not yet been conclusively established.
The evidence is strongest for depression. International treatment guidelines recommend omega-3 as an add-on to antidepressants in major depression, based on multiple randomised studies. The effect is greatest in people who already have severe symptoms; in mild low mood, virtually no benefit is visible. As a stand-alone treatment, without an antidepressant, omega-3 is insufficiently effective and is not recommended. For ADHD, bipolar disorder and schizophrenia, results are contradictory and no firm conclusions can be drawn.
Omega-3 also probably reduces inflammatory processes in the brain. This has been demonstrated in cell and animal research, but has barely been confirmed in humans. How large that effect is in humans remains unclear for now.
Against neurodegenerative diseases such as Alzheimer's, omega-3 supplements offer little to no benefit, despite population studies showing an association between high omega-3 intake and less dementia. In trials using supplements, that advantage largely disappears. A varied, healthy dietary pattern appears to offer more here than a pill. Furthermore: people who already get sufficient omega-3 benefit less from additional supplementation than someone with a genuine deficiency.
This answer is based on several large review studies, including a Cochrane review of 34 randomised studies on omega-3 in depression, international treatment guidelines based on multiple randomised studies, and a range of broader reviews on omega-3 and the brain. The evidence for the role of DHA in brain development early in life is relatively strong. For long-term brain protection and neurodegeneration, the intervention results are weak, even though the population-level associations are present. For depression as an add-on to medication, the evidence is best supported. The researchers themselves emphasise that dosage, the ratio of EPA to DHA, and blood levels prior to supplementation have a major influence on the outcome, which also explains why studies sometimes contradict one another.